Morpholino

MO3-abhd12

ID
ZDB-MRPHLNO-170308-6
Name
MO3-abhd12
Previous Names
  • MO-E10I10 (1)
Target
Sequence
5' - GGACTGGTATTCTGACCATGGAGAA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO3-abhd12
Phenotype
Phenotype resulting from MO3-abhd12
Phenotype Fish Figures
anterior lateral line neuromast GFP expression decreased amount, abnormal s356tTg + MO3-abhd12 Fig. 6 from Tingaud-Sequeira et al., 2017
anterior lateral line neuromast decreased amount, abnormal s356tTg + MO3-abhd12 Fig. 6 from Tingaud-Sequeira et al., 2017
central nervous system glial cell EGFP expression absent, abnormal ue2Tg + MO3-abhd12 Fig. 5 from Tingaud-Sequeira et al., 2017
central nervous system myelination disrupted, abnormal WT + MO3-abhd12 Fig. 5 from Tingaud-Sequeira et al., 2017
eye decreased size, abnormal WT + MO3-abhd12 Fig. 4Fig. S9 from Tingaud-Sequeira et al., 2017
eye photoreceptor cell decreased amount, abnormal WT + MO3-abhd12 Fig. 8 from Tingaud-Sequeira et al., 2017
glial cell myelination disrupted, abnormal ue2Tg + MO3-abhd12 Fig. 5Fig. S11 from Tingaud-Sequeira et al., 2017
head decreased length, abnormal WT + MO3-abhd12 Fig. S9 from Tingaud-Sequeira et al., 2017
lens opaque, abnormal WT + MO3-abhd12 Fig. 8 from Tingaud-Sequeira et al., 2017
medial longitudinal fasciculus mbpa expression decreased amount, abnormal WT + MO3-abhd12 Fig. 5 from Tingaud-Sequeira et al., 2017
posterior lateral line nerve myelinating Schwann cell mbpa expression decreased amount, abnormal WT + MO3-abhd12 Fig. 5 from Tingaud-Sequeira et al., 2017
posterior lateral line neuromast decreased amount, abnormal s356tTg + MO3-abhd12 Fig. 6 from Tingaud-Sequeira et al., 2017
posterior lateral line neuromast GFP expression decreased amount, abnormal s356tTg + MO3-abhd12 Fig. 6 from Tingaud-Sequeira et al., 2017
Purkinje cell layer corpus cerebelli morphology, abnormal WT + MO3-abhd12 Fig. 5 from Tingaud-Sequeira et al., 2017
retina layer formation disrupted, abnormal WT + MO3-abhd12 Fig. 8 from Tingaud-Sequeira et al., 2017
retinal ganglion cell layer patchy, abnormal WT + MO3-abhd12 Fig. 8 from Tingaud-Sequeira et al., 2017
retinal inner plexiform layer circular, abnormal WT + MO3-abhd12 Fig. 8 from Tingaud-Sequeira et al., 2017
retinotectal tract morphology, abnormal WT + MO3-abhd12 Fig. 8 from Tingaud-Sequeira et al., 2017
spinal cord mbpa expression decreased amount, abnormal WT + MO3-abhd12 Fig. 5 from Tingaud-Sequeira et al., 2017
swimming behavior process quality, abnormal WT + MO3-abhd12 Fig. 7 from Tingaud-Sequeira et al., 2017
thigmotaxis process quality, abnormal WT + MO3-abhd12 Fig. 7 from Tingaud-Sequeira et al., 2017
whole organism decreased length, abnormal WT + MO3-abhd12 Fig. 4Fig. S9 from Tingaud-Sequeira et al., 2017
Phenotype of all Fish created by or utilizing MO3-abhd12
Phenotype Fish Conditions Figures
retina layer formation disrupted, abnormal WT + MO3-abhd12 standard conditions Fig. 8 from Tingaud-Sequeira et al., 2017
retinal ganglion cell layer patchy, abnormal WT + MO3-abhd12 standard conditions Fig. 8 from Tingaud-Sequeira et al., 2017
medial longitudinal fasciculus mbpa expression decreased amount, abnormal WT + MO3-abhd12 standard conditions Fig. 5 from Tingaud-Sequeira et al., 2017
Purkinje cell layer corpus cerebelli morphology, abnormal WT + MO3-abhd12 standard conditions Fig. 5 from Tingaud-Sequeira et al., 2017
spinal cord mbpa expression decreased amount, abnormal WT + MO3-abhd12 standard conditions Fig. 5 from Tingaud-Sequeira et al., 2017
whole organism decreased length, abnormal WT + MO3-abhd12 standard conditions Fig. 4Fig. S9 from Tingaud-Sequeira et al., 2017
head decreased length, abnormal WT + MO3-abhd12 standard conditions Fig. S9 from Tingaud-Sequeira et al., 2017
thigmotaxis process quality, abnormal WT + MO3-abhd12 standard conditions Fig. 7 from Tingaud-Sequeira et al., 2017
retinal inner plexiform layer circular, abnormal WT + MO3-abhd12 standard conditions Fig. 8 from Tingaud-Sequeira et al., 2017
retinotectal tract morphology, abnormal WT + MO3-abhd12 standard conditions Fig. 8 from Tingaud-Sequeira et al., 2017
eye photoreceptor cell decreased amount, abnormal WT + MO3-abhd12 standard conditions Fig. 8 from Tingaud-Sequeira et al., 2017
central nervous system myelination disrupted, abnormal WT + MO3-abhd12 standard conditions Fig. 5 from Tingaud-Sequeira et al., 2017
lens opaque, abnormal WT + MO3-abhd12 standard conditions Fig. 8 from Tingaud-Sequeira et al., 2017
posterior lateral line nerve myelinating Schwann cell mbpa expression decreased amount, abnormal WT + MO3-abhd12 standard conditions Fig. 5 from Tingaud-Sequeira et al., 2017
swimming behavior process quality, abnormal WT + MO3-abhd12 standard conditions Fig. 7 from Tingaud-Sequeira et al., 2017
eye decreased size, abnormal WT + MO3-abhd12 standard conditions Fig. 4Fig. S9 from Tingaud-Sequeira et al., 2017
anterior lateral line neuromast decreased amount, abnormal s356tTg + MO3-abhd12 standard conditions Fig. 6 from Tingaud-Sequeira et al., 2017
posterior lateral line neuromast decreased amount, abnormal s356tTg + MO3-abhd12 standard conditions Fig. 6 from Tingaud-Sequeira et al., 2017
posterior lateral line neuromast GFP expression decreased amount, abnormal s356tTg + MO3-abhd12 standard conditions Fig. 6 from Tingaud-Sequeira et al., 2017
anterior lateral line neuromast GFP expression decreased amount, abnormal s356tTg + MO3-abhd12 standard conditions Fig. 6 from Tingaud-Sequeira et al., 2017
central nervous system glial cell EGFP expression absent, abnormal ue2Tg + MO3-abhd12 standard conditions Fig. 5 from Tingaud-Sequeira et al., 2017
glial cell myelination disrupted, abnormal ue2Tg + MO3-abhd12 standard conditions Fig. 5Fig. S11 from Tingaud-Sequeira et al., 2017
Citations